| Vol. 14.02 – 20 January, 2022 |
| |
|
|
| Investigators used an accurate, single-cell whole genome sequencing approach to show that telomerized primary mammary epithelial cells heterozygous for a highly penetrant BRCA1 variant displayed a robustly elevated mutation frequency as compared to their isogenic control cells. [Journal of Clinical Investigation] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers revealed a critical role for HOXC-AS3 in regulating the metabolic reprogramming of breast cancer cells under metabolic stress. [Cancer Research] |
|
|
|
| Investigators analyzed lineage-dependent gene expression in human breast tumors to identify differences in metabolic gene expression that may limit pathway redundancy and create therapeutic vulnerabilities. [Cell Reports] |
|
|
|
| The authors reported an epithelium-intrinsic requirement for Zeb1, a core transcriptional inducer of epithelial-to-mesenchymal transition (EMT), for mammary epithelial ductal side branching and for basal cell regenerative capacity. [Cell Reports] |
|
|
|
| Researchers demonstrated that STAT3 was essential for the pro-tumorigenic functions of murine breast cancer associated fibroblasts both in vitro and in vivo, and identified a STAT3 signature significantly enriched for genes encoding for secreted proteins. [Oncogene] |
|
|
|
| Scientists showed that reverting the high liver-enriched inhibitory protein (LIP)/liver-enriched activating protein (LAP) ratios in TNBC cell lines into low LIP/LAP ratios by overexpression of LAP reduced migration and matrix invasion of these TNBC cells. [npj Breast Cancer] |
|
|
|
| The authors evaluated the transcriptome of an extended series of inflammatory breast cancer (IBC) preclinical models and performed a comparative analysis with patient samples to determine the extent to which the current models recapitulated the molecular characteristics of IBC observed clinically. [npj Breast Cancer] |
|
|
|
| Scientists investigated the potential involvement of CLK4 in the metastasis and progression of mesenchymal (MES)-like TNBC. In the MES-TNBC cell lines, the CLK4 expression was elevated. [Cancer Gene Therapy] |
|
|
|
| H. leucospilota was collected, the methanolic extract was prepared and in vitro cytotoxicity of H. leucospilota extract in the range of 12.5, 25, 50, 100, and 200 μg/mL concentrations for 48 hours on SK-BR-3 and MCR5 cells was determined. [Molecular Biology Reports] |
|
|
|
| Researchers demonstrated selective binding, effective uptake of herceptin (HER)-conjugated magnetic polystyrene-Agsbox nanoparticles into MDA-MB-231and SKBR-3 cell lines with no effect against L929. [Journal of Biomaterials Applications] |
|
|
|
|
| The authors cover the evolution and latest updates of the CAP/ASCO guidelines relevant to ER and HER2 biomarkers in breast cancer. [Virchows Archiv] |
|
|
|
|
By combining established prognostic factors with valid prognostic/predicted biomarkers, scientists can start the journey to personalized treatment for every recently diagnosed breast cancer patient. [Clinical and Experimental Medicine] |
| |
|
|
| Syapse® announced that Pfizer will continue working with Syapse to advance the use of real-world data from the Syapse Learning Health Network™ as an extension of the organizations’ ongoing collaboration. Syapse will maintain clinical abstractions resources to continue to grow the breast cancer data cohort. [Syapse®] |
|
|
|
|
|
|
|
| The Wistar Institute – Philadelphia, Pennsylvania, United States |
|
|
|
| Brigham and Women’s Hospital – Boston, Massachusetts, United States |
|
|
|
| Charity-University Medicine Berlin – Berlin, Germany |
|
|
|
| The University of Texas Southwestern Medical Center – Dallas, Texas, United States |
|
|
|
| Leiden University – Leiden, United Kingdom |
|
|
|
|